Agenda

NASP Meeting Agenda

The 7th NASP Annual Meeting & Expo​ will provide comprehensive information regarding all aspects of specialty pharmacy, including the evolution of the market, impact of specialty pharmacy on patients, and national legislative and regulatory policy. The meeting will also include a Specialty Pharmacy Law Conference offering CE and CLE credits to attendees; a one-day CSP Prep Course for pharmacists studying for October examinations given by the Specialty Pharmacy Certification Board for Certified Specialty Pharmacist certification; and a Home Infusion Post-Conference Workshop given by subject matter experts from the National Home Infusion Association (NHIA) offering CE credits to attendees.

To view all available sessions, click the + icon under Track.

NASP 2019 Schedule

Download PDF
Monday September 09, 2019
Time
Track
Session/Events
Faculty
Room Moderator
Meeting Room
08:00 AM - 08:00 PM
NASP Annual Meeting & Expo Registration
Ballroom Foyer
12:00 PM - 01:15 PM
CE Satellite Symposium (lunch provided)

 

Maryland
01:30 PM - 02:55 PM
Welcome

Welcome, NASP Year in Review, Presentation of Specialty Pharmacy of the Year, Welcome New BOD, Welcoming Student Chapter Members, and NASP Distinguished Service to Specialty Pharmacy

Carmine DeNardo, RPh

Sheila Arquette, RPh,

Ballroom
02:55 PM - 03:00 PM
Keynote Introduction

Carmine DeNardo, RPh

Ballroom
03:00 PM - 03:45 PM
Keynote Presentation

Boomer Esiason

Ballroom
03:45 PM - 04:00 PM
Audience Question & Answer
Ballroom
04:00 PM - 06:00 PM
Day 1 Annual Meeting Educational Conference Sessions
04:00 PM - 05:00 PM
Clinical C1
2019 State of Care: Cystic Fibrosis

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Ryan Atkinson, PharmD, MBA

Jessie Heaton, PharmD,

Virginia
04:00 PM - 05:00 PM
Operational O6
Reimbursement Revealed: The Patient Impact Behind the Smoke and Mirrors

Learning Objectives:

  • Assess the role of co-pay accumulators in patient benefit management.
  • Contrast best practices regarding use of third-party financial support, including foundation programs, co-pay cards, and patient assistance programs.
  • Discuss cost control and management opportunities from patient through payer.

Charles E. Collins, Jr., MS MBA

Krista Zodet, MSW,

Maryland
04:00 PM - 05:00 PM
Regulatory R3
Beyond the Trump Administration: Blueprint to Lower Drug Prices in MedicareŚKey Highlights, Actions, and Challenges Affecting Specialty Pharmacy

Learning Objectives:

  • Analyze proposed areas of reform, including Medicare Part D pharmacy direct and indirect remuneration, Medicare Part D rebates, and Medicare Part B.
  • Outline the effects on Medicare Part D protected classes.
  • Assess the Medicare 340B program, including legal challenges and impacts.

Kara Cardinale, MPAff

Delaware A
05:00 PM - 06:00 PM
Clinical C4
2019 State of Care: Multiple Sclerosis

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process

Lauren Downing, PharmD

Virginia
05:00 PM - 06:00 PM
Regulatory R4
Biosimilar Action Plan

Learning Objectives:

  • Outline components of the FDA’s Biosimilar Action Plan.
  • Discuss current status of plan and changes that have occurred since introduction.
  • Review current slate of biosimilar medications and the action plan’s proposed impact on industry segment growth.

Ron Lanton, Esq.

Delaware A
05:00 PM - 06:00 PM
Experience E2
What is Keeping Employers Up at Night? Challenges & Opportunities in Managing Specialty Drugs

Learning Objectives:

  • Describe the key trends that are impacting employer plan sponsors in managing specialty drugs
  • Recognize what matters to them when partnering with specialty pharmacies
  • Identify what employer models are having an impact on costs and patient outcomes

Cheryl Larson

Ballroom
05:30 PM - 06:15 PM
Attendee Meet & Greet with Boomer Esiason
Exhibit Hall
06:00 PM - 07:00 PM
CE Satellite Symposium (dinner provided)
Maryland
06:00 PM - 08:00 PM
Welcome Reception and Networking including the 2nd Annual NASP Gives Back Fundraiser
Exhibit Hall
Tuesday September 10, 2019
Time
Track
Session/Events
Faculty
Room Moderator
Meeting Room
06:00 AM - 07:00 AM
Wellness Initiative: Yoga (limited space, on-site sign up required)

Cheryl Allen, BS Pharm MBA

07:00 AM - 08:00 AM
CE Satellite Symposium (breakfast provided)
Maryland
07:00 AM - 08:00 AM
Breakfast
Exhibit Hall
07:00 AM - 08:00 PM
NASP Annual Meeting & Expo Registration
Ballroom Foyer
08:00 AM - 08:30 AM
Welcome

Welcome and recap of Monday, September 9, 2019

Carmine DeNardo, RPh

Ballroom
08:30 AM - 10:30 AM
Day 2 Annual Meeting Educational Conference Sessions
08:30 AM - 09:30 AM
Clinical C1
2019 State of Care: Cystic Fibrosis

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Ryan Atkinson, PharmD, MBA

Jessie Heaton, PharmD,

Virginia
08:30 AM - 09:30 AM
Regulatory R5
Partnering With NASP: SPCB Update & Patient Survey Results

Learning Objectives:

  • Discuss the SPC Board partnership and current state of the Certified Specialty Pharmacist Program, including industry acceptance.
  • Report results of the Specialty Pharmacy Satisfaction Survey, focused on multiple stakeholder perspectives.

Thomas P. Jeffrey

Brandon J. Newman, PharmD, MMHC, CSP,

Suzette DiMascio, CHE, CMCE, CPC,

Jay J. Garvey, MBA,

Barbara J. Sylvester, RN, BBA, MSOLQ,

Delaware A
08:30 AM - 09:30 AM
Experience E1
Innovation in Specialty: Pharmacogenomics, Artificial Intelligence, and Beyond

Learning Objectives:

  • Review key pharmacogenomics trends and case examples of its use in specialty pharmacy practice.
  • Predict what the future holds for specialty pharmacy and artificial intelligence.
  • Propose how technology and specialty pharmacy can maintain a synergistic model to benefit all stakeholders.

Rebecca Bigler, PhD

Cory D. Kidd, PhD,

Luis Rodriguez,

Ballroom
09:30 AM - 10:30 AM
Clinical C2
2019 State of Care: Hepatology (HEPC, NASH)

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Russel R. Allinson, RPh, MS

Lily P. Duong, PharmD, RPh,

Amber N. Rollo, PharmD,

Virginia
09:30 AM - 10:30 AM
Operational O2
Intake: Building Positive Relationships With Prescribers During Patient Onboarding

Learning Objectives:

  • Describe the referral management process and steps to receipt of referral.
  • Identify points of confusion related to intake and how to surmount challenges.
  • Compare best practices in specialty pharmacy–prescriber relationships to decrease time to fill.

Kyle Skiermont, PharmD

Maryland
09:30 AM - 10:30 AM
Regulatory R2
Managing Regulations

Learning Objectives:

  • Recognize regulations affecting pharmacy operations, including prescription drug management programs, nonresident licensure, and accreditation.
  • Formulate key steps a pharmacy can take to ensure compliance with aforementioned regulations.
  • Discuss best practices of specialty pharmacies that have ensured both compliance and efficiency in gaining compliance.

Timothy Safley, MBA

Heather Bonome, PharmD,

Bradley W. Howard,

Delaware A
10:30 AM - 11:00 AM
AM Break
Exhibit Hall
11:00 AM - 12:00 PM
Day 2 Annual Meeting Educational Conference Sessions

  

11:00 AM - 12:00 PM
Clinical C3
2019 State of Care: Inflammatory Diseases (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis)

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Elizabeth Duruz, RPh, CSP

Nancy Crowell, RPh,

Virginia
11:00 AM - 12:00 PM
Operational O3
Fulfillment: Aligning Processes to Best Standards of Care

Learning Objectives:

  • Review updates to prescription handling and cold chain management standards.
  • Discuss best practices to comply with the Drug Supply Chain Security Act.
  • Describe advancements in packaging, returns handling, and other areas of the fulfillment process.

Tim Ward, Esq.

Mischelle C. Smoot, RPh,

Maryland
11:00 AM - 12:00 PM
Experience E7
Practical Application of Interactive Robotics

Learning Objectives:

  • Describe examples of how AI can be used to gain insights across a patient journey receiving specialty medications.
  • Explain the state of the art for using artificial intelligence and interactive robots for patient engagement and revealing challenges of symptom management and patient behaviors (outside of a clinical environment) and factors that may cause adherence issues.
  • Identify how to bring these models to market for pilots and ultimately to deploy in the real world with patients.

Cory D. Kidd, PhD

Debra Fickert,

Stephen M. Lund, RPh,

Ballroom
12:00 PM - 01:00 PM
Lunch Break (lunch provided in Exhibit Hall)
Exhibit Hall
12:15 PM - 01:15 PM
CE Satellite Symposium (lunch provided)
Maryland
01:00 PM - 02:00 PM
Networking
Delaware B
02:00 PM - 02:25 PM
Presentation of NASP Scholarships

Scholarship Committee

Ballroom
02:25 PM - 02:30 PM
Keynote Introduction

  

Carmine DeNardo, RPh

Ballroom
02:30 PM - 03:30 PM
Keynote Presentation

Andy Slavitt

Ballroom
03:30 PM - 04:30 PM
Day 2 Annual Meeting Educational Conference Sessions
03:30 PM - 04:30 PM
Clinical C5
2019 State of Care: Oncology / Hematology

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Joseph V. Barone, PharmD, BCOP

Virginia
03:30 PM - 04:30 PM
Operational O5
Improving Data Standards for Specialty Pharmacy - A Multi-Stakeholder Panel (HUB, Aggregator, NCPDP, SP, Pharma partners)

Learning Objectives:

  • Recognize key data elements shared across the specialty pharmacy industry.
  • Identify elements of standardization attempted by each stakeholder on the panel.
  • Describe challenges to further standardization of data and ways to overcome them.

Phillip D. Scott

Lynn M. Pezzullo. RPh,

Ken Engels,

Maryland
03:30 PM - 04:30 PM
Regulatory R1
NASP in Action- Your Association's Effort to Be the Voice for Specialty Pharmacy in Washington, DC

Learning Objectives:

  • Review policy priorities and position statements supported by NASP.
  • Outline congressional and regulatory action.
  • Illustrate the role of the NASP Political Action Committee, along with other NASP grassroots efforts.

Nick Calla, RPh, Esq.

Julie Scott Allen,

Erik D. Halstrom, MBA,

Delaware A
04:30 PM - 05:30 PM
PM Break with Attendee Meet & Greet with Andy Slavitt
Exhibit Hall
05:00 PM - 06:00 PM
Day 2 Annual Meeting Educational Conference Sessions

  

05:00 PM - 06:00 PM
Clinical C6
2019 Pipeline Review

Meeting Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Ray Tancredi, RPh, MBA, CSP

Virginia
05:00 PM - 06:00 PM
Operational O6
Reimbursement Revealed: The Patient Impact Behind the Smoke and Mirrors

Learning Objectives:

  • Assess the role of co-pay accumulators in patient benefit management.
  • Contrast best practices regarding use of third-party financial support, including foundation programs, co-pay cards, and patient assistance programs.
  • Discuss cost control and management opportunities from patient through payer.

Charles E. Collins, Jr., MS MBA

Krista Zodet, MSW,

Maryland
05:00 PM - 06:00 PM
Experience E6
Manufacturer-Specialty Pharmacy Relationships: A Model for Commercial Success

Learning Objectives:

  • Discuss best-case relationships between specialty pharmacies and manufacturers, including clinical programs.
  • Illustrate approaches to specialty pharmacy contracting, including key takeaways for capabilities and cost management.
  • Review case examples of high-performing limited distribution models and the pros and cons across the supply chain.

Natalie Bedford

Paula Bickley,

Benito Fernandez,

Ballroom
06:00 PM - 07:00 PM
CE Satellite Symposium (dinner provided)
Maryland
06:30 PM - 07:30 PM
Poster Presentations and Author Discussions

 

Exhibit Hall
06:30 PM - 08:00 PM
Getting to Know You: NASP BOD Reception for Attendees, Sponsors, and Exhibitors
Exhibit Hall
Wednesday September 11, 2019
Time
Track
Session/Events
Faculty
Room Moderator
Meeting Room
06:00 AM - 07:00 AM
Wellness Initiative (limited space, on-site sign up required)

 

07:00 AM - 08:00 AM
CE Satellite Symposium (breakfast provided)
Maryland
07:00 AM - 08:00 AM
Breakfast

 

Exhibit Hall
07:00 AM - 08:00 AM
PAC Breakfast (requires separate registration fee)
Wilson ABC
07:00 AM - 04:00 PM
NASP Annual Meeting & Expo Registration
08:00 AM - 08:45 AM
Welcome

Recap of Tuesday, September 10, 2019 and Poster Awards Presentation

Carmine DeNardo, RPh

Rich Brook,

Sheila Arquette, RPh,

Ballroom
08:45 AM - 09:45 AM
Product Pipeline Update: Specialty Pharmaceutical Trends and Outlook

Learning Objectives:

  • Discuss challenges faced by specialty pharmacies, including reimbursement, regulation, and pricing.
  • Analyze growth trends in specialty over the last several years.
  • Predict future opportunities for specialty pharmacy.

Doug Long, MBA

Sheila Arquette, RPh,

Ballroom
09:45 AM - 10:45 AM
Day 3 Annual Meeting Educational Conference Sessions

 

09:45 AM - 10:45 AM
Clinical C2
2019 State of Care: Hepatology (HEPC, NASH)

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Russel R. Allinson, RPh, MS

Lily P. Duong, PharmD, RPh,

Amber N. Rollo, PharmD,

Virginia
09:45 AM - 10:45 AM
Operational O5
Improving Data Standards for Specialty Pharmacy

Learning Objectives:

  • Recognize key data elements shared across the specialty pharmacy industry.
  • Identify elements of standardization attempted by each stakeholder on the panel.
  • Describe challenges to further standardization of data and ways to overcome them.

Phillip D. Scott

Lynn M. Pezzullo. RPh,

Ken Engels,

Maryland
09:45 AM - 10:45 AM
Experience E4
Health-System Pharmacy: Enhancing Transitions Across Multiple Sites of Care

Learning Objectives:

  • Assess the landscape of health-system specialty pharmacy growth.
  • Propose models of efficiency related to health-system, integrated delivery, or hybrid models of care.
  • Discuss practice pearls for managing transition of care from diagnosis through outpatient journey, as well as foundational inquiries about the process of building a health-system specialty pharmacy.

Vaughn Kinosian, RPh

Brett J. Healy, PharmD, MS, CSP,

Ballroom
10:45 AM - 11:15 AM
AM Break

 

Exhibit Hall
11:15 AM - 01:15 PM
Day 3 Annual Meeting Educational Conference Sessions
11:15 AM - 12:15 PM
Clinical C3
2019 State of Care: Inflammatory Diseases (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis)

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Elizabeth Duruz, RPh, CSP

Nancy Crowell, RPh,

Virginia
11:15 AM - 12:15 PM
Operational O7
Rare Disease Panel

Learning Objectives:

  • Review multistakeholder considerations for rare disease therapy management, including accreditors, specialty pharmacies, payers, and geneticists.
  • Examine the impact of rare disease therapies on each of the associated stakeholders using case studies.
  • Discuss best practices for handling and managing rare disease therapies within the specialty pharmacy continuum.

Justin Smerker, PharmD, MPBA

Lisa R. Massey,

Maryland
11:15 AM - 12:15 PM
Experience E1
Innovation in Specialty: Pharmacogenomics, Artificial Intelligence, and Beyond

Learning Objectives:

  • Review key pharmacogenomics trends and case examples of its use in specialty pharmacy practice.
  • Predict what the future holds for specialty pharmacy and artificial intelligence.
  • Propose how technology and specialty pharmacy can maintain a synergistic model to benefit all stakeholders.

Rebecca Bigler, PhD

Cory D. Kidd, PhD,

Luis Rodriguez,

Ballroom
12:15 PM - 01:15 PM
Operational O4
Streamlining the Specialty Prescribing Process: How Technology Can Accelerate Time to Therapy

Learning Objectives:

  • Define the role technology plays in speed to therapy.
  • Identify the challenges in specialty prescribing.
  • Articulate the outcomes seen from use of technology solutions in specialty prescribing.

Kathy Lewis, MPH

Maryland
12:15 PM - 01:15 PM
Clinical C4
2019 State of Care: Multiple Sclerosis

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Lauren Downing, PharmD

Virginia
12:15 PM - 01:15 PM
Regulatory R6
Reforming Direct and Indirect Remuneration Fees- Administrative and Legislative Efforts to Get There

Meeting Objectives:

  • Evaluate the response from the Trump administration related to direct and indirect remuneration fees and the impact on specialty practice.
  • Examine the historical level of congressional engagement.
  • Apply tactics for pharmacy advocacy: What more can you do?

Julie Scott Allen

Delaware A
01:15 PM - 02:30 PM
Women in Specialty Pharmacy Luncheon (requires separate registration)

Allison Massari

Wilson ABC
01:15 PM - 02:00 PM
Lunch Break (lunch provided in Exhibit Hall)
Exhibit Hall
01:30 PM - 02:30 PM
CE Satellite Symposium (lunch provided)
Maryland
02:00 PM - 02:30 PM
Networking
Delaware B
02:30 PM - 04:30 PM
Day 3 Annual Meeting Educational Conference Sessions
02:30 PM - 03:30 PM
Clinical C5
2019 State of Care: Oncology / Hematology

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Joseph V. Barone, PharmD, BCOP

Virginia
02:30 PM - 03:30 PM
Operational O1
Industry Disruptors in Network Design

Learning Objectives:

  • Review of trends leading to the need for differentiation to attract attention of partners
  • Describe key components of innovative care models where high-quality, cost-effective care is being rewarded with network access – both payer and pharmacy
  • Illustrate steps specialty pharmacies can take to capture the attention of forward-thinking contract programs

Cheryl Allen, BS Pharm MBA

Flaviu Simihaian, MS,

Craig Vollmer,

Maryland
02:30 PM - 03:30 PM
Experience E3
Living in a Value-Based World

Learning Objectives:

  • Review related concepts and case examples of value-based care.
  • Analyze key learnings from specialty pharmacy involvement in outcomes management and true value-based care.
  • Identify key areas for specialty pharmacy growth to aid in this area.

Sabrina M. Livezey, PharmD, CSP

Jacob A. Jolly, PharmD, CSP,

Ballroom
03:30 PM - 04:30 PM
Clinical C6
2019 Pipeline Review

Learning Objectives:

  • Examine current standards of care within the disease area.
  • Identify new agents approved over the past 12 months.
  • Examine clinical pearls and best practices for clinically managing patients within the disease process.

Ray Tancredi, RPh, MBA, CSP

Virginia
03:30 PM - 04:30 PM
Regulatory R2
Managing Regulations

Learning Objectives:

  • Recognize regulations affecting pharmacy operations, including prescription drug management programs, nonresident licensure, and accreditation.
  • Formulate key steps a pharmacy can take to ensure compliance with aforementioned regulations.
  • Discuss best practices of specialty pharmacies that have ensured both compliance and efficiency in gaining compliance.

Timothy Safley, MBA

Heather Bonome, PharmD,

Bradley W. Howard,

Delaware A
03:30 PM - 04:30 PM
Experience E5
Enhanced Services & the Patient JourneyŚCoordinating Care to Ensure Patient Success

Learning Objectives:

  • Differentiate core and enhanced specialty pharmacy offerings.
  • Compare different service models, including internal and external hub service providers.
  • Illustrate successful enhanced service programs and the value afforded to the patient journey, including staffing models with nursing.

Julie Zatizibal, MT, ASCP

Douglas Gebhard,

Shannon Wiley,

Ballroom
04:30 PM - 05:00 PM
Annual Meeting Adjournment

Michael T. Einodshofer, MBA

07:15 PM - 11:30 PM
Monuments at Night Tour

NASP is offering a bus tour of the Capitol's most iconic monuments and memorials on September 11, 2019.

Included in the tour are:

  • National 9/11 Pentagon Memorial
  • US Capitol Building
  • Whtie House
  • World War II Memorial
  • Lincoln Memorial
  • Vietnam Veterans Memorial
  • The National Archives
  • Washington Monument
  • The Holocaust Museum
  • FBI Headquarters
Please be in the lobby and prepared to leave by 7:15pm.

Space is limited - due to popular demand, it is now available to the first 120 registrants.  Bring a guest!
Reserve your spot by registering for the tour here.
 

Thursday September 12, 2019
Time
Track
Session/Events
Faculty
Room Moderator
Meeting Room
07:00 AM - 08:00 AM
Post-Conference Workshops Registration and Breakfast

 

07:00 AM - 02:30 PM
Home Infusion Workshop (requires separate registration and fee)
Washington 3
07:00 AM - 08:00 AM
Home Infusion

Breakfast

Washington 3
08:00 AM - 08:10 AM
Home Infusion

Welcome & Introductions

Washington 3
08:10 AM - 09:45 AM
Home Infusion

Sterile Compounding Regulatory Climate, Accreditation, Data, Patient Satisfaction

Washington 3
09:45 AM - 10:00 AM
Home Infusion

Break

Washington 3
10:00 AM - 11:30 AM
Home Infusion

General Operations - Referral Flow, Staffing Roles, Compliance, Patient Oversight, Infusion Devices/Standards, Management of Home Environment

Washington 3
11:30 AM - 12:30 PM
Home Infusion

Lunch

Washington 3
12:30 PM - 01:30 PM
Home Infusion

Reimbusement - Reimbursement Commercial, Medicare, Medicaid, Challenges 

Washington 3
01:30 PM - 02:30 PM
Home Infusion

Government Affairs - Overview of current events related to legislation

Washington 3
02:30 PM - 02:45 PM
Home Infusion

Closing remarks and Adjourn

Washington 3
07:30 AM - 04:00 PM
CSP Exam Prep Course (requires separate registration and fee)
Washington 2
07:30 AM - 08:30 AM
CSP Exam Prep Course

Intake, Fulfillment, Outcomes

Mel Nelson, PharmD, CSP

Rushabh Shah, PharmD, MBA, AAHIVP, CSP,

Washington 2
08:30 AM - 09:30 AM
CSP Exam Prep Course

Inflammatory Diseases

April Jones, PharmD, CSP

Washington 2
09:30 AM - 09:45 AM
CSP Exam Prep Course

Osteoporosis

Kevn McNamara, PharmD, CNSC, PRS, CVAA(c), CSP

Washington 2
09:45 AM - 10:00 AM
CSP Exam Prep Course

Break

Washington 2
10:00 AM - 11:00 AM
CSP Exam Prep Course

Oncology

Marcy Snell, PharmD, CSP

Washington 2
11:00 AM - 11:15 AM
CSP Exam Prep Course

Transplant

Marcy Snell, PharmD, CSP

Washington 2
11:15 AM - 11:30 AM
CSP Exam Prep Course

Infertility

Marcy Snell, PharmD, CSP

Washington 2
11:30 AM - 11:45 AM
CSP ExamPrep Course

Part 1 Q & A

Washington 2
11:30 AM - 12:15 AM
CSP Exam Prep Course

Lunch Break (Including Part 1 Q & A)

Washington 2
12:15 PM - 01:15 PM
CSP Exam Prep Course

Multiple Sclerosis & Neurological Conditions

Selina Mullins, PharmD, MBA

Washington 2
01:15 PM - 02:15 PM
CSP Exam Prep Course

Hep C, HIV, CF

Kristen Whelchel, PharmD

Washington 2
02:15 PM - 02:30 PM
CSP Exam Prep Course

Break

Washington 2
02:30 PM - 02:50 PM
CSP Exam Prep Course

Pulmonary Arterial Hypertension & Cardiology

Brenda Gray, PharmD, BCNSP, CNSC, VA-BC, CVAA(c), PRS

Washington 2
02:50 PM - 03:05 PM
CSP Exam Prep Course

RSV

Brenda Gray, PharmD, BCNSP, CNSC, VA-BC, CVAA(c), PRS

Washington 2
03:05 PM - 03:20 PM
CSP Exam Prep Course

Growth Hormone

Brenda Gray, PharmD, BCNSP, CNSC, VA-BC, CVAA(c), PRS

Washington 2
03:20 PM - 03:35 PM
CSP Exam Prep Course

Immunoglobulins

Erin Mellerski, PharmD, CSP

Washington 2
03:35 PM - 03:50 PM
CSP Exam Prep Course

Hemophilia

Erin Mellerski, PharmD, CSP

Washington 2
03:50 PM - 04:05 PM
CSP Exam Prep Course

Part 2 Q & A

Washington 2
04:05 PM - 04:10 PM
CSP Exam Prep Course

Adjournment

Washington 2
08:00 AM - 06:00 PM
NASP 4th Annual Specialty Pharmacy Law Conference - Legal Day (requires separate registration and fee)
Washington 4
07:00 AM - 08:00 AM
Legal Day
Breakfast
08:00 AM - 08:20 AM
Legal Day
Welcome and Market Overview
08:20 AM - 09:20 AM
Legal Day
Legal Issues Facing Compounding Pharmacies During the Next 12 Months
09:20 AM - 09:40 AM
Legal Day
Break
09:40 AM - 10:40 AM
Legal Day
General Regulatory (Pharmacy Law, 340B, and Privacy Update)
10:40 AM - 11:40 PM
Legal Day
Preparing for and Responding to PBM and Other Third-Party Payer Audits
11:40 AM - 12:30 PM
Legal Day
Lunch
12:30 PM - 01:30 PM
Legal Day
Structuring Legally Compliant Relationships With Physicians and Other Referral Sources
01:30 PM - 02:30 PM
Legal Day
Value-Added Services That Can Legally Be Provided by Pharmaceutical Manufacturers
02:30 PM - 02:50 PM
Legal Day
Break
02:50 PM - 03:50 PM
Legal Day
Telepharmacy, Telemedicine, AIC, and Other Alternative Sites of Care
03:50 PM - 04:50 PM
Legal Day
Compliance Issues Facing Hospital-Based Specialty Pharmacies
04:50 PM - 05:00 PM
Legal Day
Closing and Adjournment
 
*Final agenda will be posted in September 2019